This is a preview of subscription content, log in via an institution to check access.
Data Availability
The data generated during and/or analyzed for this report is available from the corresponding author on reasonable request.
References
Dorjbal B, Stinson JR, Ma CA, Weinreich MA, Miraghazadeh B, Hartberger JM, et al. Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease. J Allergy Clin Immunol. 2019;143(4):1482–95.
Meitlis I, Allenspach EJ, Bauman BM, Phan IQ, Dabbah G, Schmitt EG, et al. Multiplexed functional assessment of genetic variants in CARD11. Am J Hum Genet. 2020;107(6):1029–43.
Bedsaul JR, Carter NM, Deibel KE, Hutcherson SM, Jones TA, Wang Z, et al. Mechanisms of regulated and dysregulated CARD11 signaling in adaptive immunity and disease. Front Immunol. 2018;9:2105.
Lu HY, Bauman BM, Arjunaraja S, Dorjbal B, Milner JD, Snow AL, et al. The CBM-opathies—a rapidly expanding spectrum of human inborn errors of immunity caused by mutations in the CARD11-BCL10-MALT1 complex. Front Immunol. 2018;9:2078.
Pomerantz JL, Milner JD, Snow AL. Elevated IgE from attenuated CARD11 signaling: lessons from atopic mice and humans. CurrOpin Immunol. 2022;79:102255.
Urdinez L, Erra L, Palma AM, Mercogliano MF, Fernandez JB, Prieto E, et al. Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: a single center experience. Front Immunol. 2022;13. https://doi.org/10.3389/fimmu.2022.1020927
Pietzsch L, Körholz J, Boschann F, Sergon M, Dorjbal B, Yee D, et al. Hyper-IgE and carcinoma in CADINS disease. Front Immunol. 2022;13. https://doi.org/10.3389/fimmu.2022.878989
Zampetti A, Giurdanella F, Manco S, Linder D, Gnarra M, Guerriero G, et al. Acquired epidermodysplasia verruciformis: a comprehensive review and a proposal for treatment. Dermatol Surg. 2013;39(7):974–80.
Acknowledgements
The authors thank the patient and his family for their participation.
PID PGI Consortium:
Sumit Goel1, Vinay Keshavamurthy3, Aravind Sekar4, Amit Rawat1
1Department of Pediatrics, Advanced Pediatrics Center,Postgraduate Institute of Medical Education and Research, Chandigarh – 160012, India.
3Department of Dermatology, Venerology, and Leprosy, Postgraduate Institute of Medical Education and Research, Chandigarh – 160012, India.
4Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh – 160012, India.
Funding
P.V. received funding from the Indian Council of Medical Research, Government of India, for carrying out the project entitled, “Clinical and Molecular Evaluation of Inborn Errors of Immunity in a tertiary care centre of North India” (No. 33/29–2/2019-TF/Rare/BMS). A.L.S. received funding from the National Institutes of Health (1R01AI168295).
Author information
Authors and Affiliations
Consortia
Contributions
Diagnosis and management of the case were done by Ridhima Aggarwal and Pandiarajan Vignesh. PGI PID Consortium was involved in clinical diagnosis (VK), immunological (AR, JD, SG), and histopathological (AS) investigations. Variant testing experiments were conducted by Alison R. Spratt and Andrew L. Snow. The first draft of the manuscript was written by Ridhima Aggarwal and Alison R. Spratt. Manuscript supervision was done by Pandiarajan Vignesh and Andrew L. Snow. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics Approval
Approval was granted by the Departmental Review Board of Advanced Pediatric Centre of Post Graduate Institute of Medical Education and Research (No.: DRB-45–23, Date: 20–06-23).
Consent to Participate
Informed consent was obtained from the individual participant reported.
Consent for Publication
The authors affirm that the individual participant provided informed consent for publication of information and images.
Competing Interests
The authors declare no competing interests.
Disclaimer
The opinions and assertions expressed herein are those of the authors and are not to be construed as reflecting the views of the Uniformed Services University of the Health Sciences or the United States Department of Defense.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Aggarwal, R., Spratt, A.R., PID PGI Consortium. et al. Epidermodysplasia Verruciformis in CADINS Disease: Expanding the Phenotype. J Clin Immunol 44, 58 (2024). https://doi.org/10.1007/s10875-024-01663-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10875-024-01663-3